Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
2013 · The Lancet Neurology · 232 citations
https://doi.org/10.1016/s1474-4422(13)70221-7
A
Adam L. Meyers
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
809
Citations
16
h-index
17
i10-index
Adam L. Meyers is an academic researcher from University of Miami. The author has contributed to research in topics: Treatment of Major Depression & Schizophrenia research and treatment & Bipolar Disorder and Treatment. The author has an h-index of 16, co-authored 29 publications.
Papers by this author
worksEarly Symptom Change Prediction of Remission in Depression Treatment
2025 · Psychopharmacology Bulletin · 40 citations
https://doi.org/10.64719/pb.4097
A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode
2011 · International Clinical Psychopharmacology · 29 citations
https://doi.org/10.1097/yic.0b013e32834ce11b
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat